secwatch / observer
8-K filed October 10, 2023, 7:59 PM ET CIK 0001499785
other material confidence high sentiment negative materiality 0.85

Tengjun Biotechnology Corp.: auditor change — Tengjun Biotechnology terminates auditor PWN LLP after accounting disagreements; appoints KG CPA LLP

Tengjun Biotechnology Corp.

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Tengjun Biotechnology Corp. dismissed PWN LLP as its auditor.

Action
dismissal
Auditor
PWN LLP
Successor
KG CPA LLP
Exact text from the filing
lected not to continue the engagement of PWN LLP serving as the Company’s independent registered public accounting firm. The termination of the engagement of PWN LLP has been approved by the Board of Directors of the Company (the “Board”). The report of PWN LLP on the financial statements of the Company as of and for the fiscal year ended December 31, 2022 did not contain any adverse opinion or disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope or accounting principles. During the Company’s two most recent fiscal years and the subsequent interim period through October 2, 2023, there were disagreements with PWN LLP regarding certain accounting treatments. Due to the provision of incorrect accounting information by the Company, PWN LLP discovered significant discrepancies and inconsistencies in the data when reviewing the Company’s second quarter financi
View on SEC.gov
Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Tengjun Biotechnology Corp. engaged KG CPA LLP as its auditor.

Action
engagement
Auditor
KG CPA LLP
Exact text from the filing
the Board approved the engagement of KG CPA LLP as the Company’s new independent registered public accounting firm with effect from October 2, 2023.
View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR
accession 0001013762-23-002833
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.